UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Finding immediate cash help can alleviate financial stress. Discover various resources available to assist you in urgent situations.
23,736 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
A high-earning couple uses a careful 401(k) roth bracket filling plan to convert pre-tax dollars to Roth over eight y...
A fresh market thesis argues ethereum could outperform bitcoin this year as on-chain economics favor ETH, even as pri...
Red Cat Holdings faced a sharp price move after news about a government contract came with unclear value. This articl...
A wave of consolidation in homebuilding is driven by scale and access to the foreign capital market, reshaping how de...
A veteran fund manager challenges Wall Street's reliance on earnings when valuing AI plays, arguing that the E in P/E...
Russia is moving toward a broader embrace of its digital ruble, with key banks and merchants prepared to accept it by...
Rocket Lab’s stock jumped about 118% in the last year, but a big move doesn’t always mean a lasting uptrend. This art...
As AI accelerates, Greg Abel is steering Berkshire Hathaway Energy to prepare for higher data-center electricity dema...
Investors ask if Apple stock should be bought before April 30. This guide offers a clear framework, real-world exampl...
Gap reports eight straight quarters of positive comps and a multi-decade margin high, prompting a televised reaction ...
Retirees weigh claiming at 62 vs waiting to FRA in 2026 as Dave Ramsey’s controversial guidance remains hot. This pie...